KINEPOLIS (KIN.BR) Fundamental Analysis & Valuation

EBR:KIN • BE0974274061

Current stock price

26.6 EUR
+0.1 (+0.38%)
Last:

This KIN.BR fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

6

1. KIN.BR Profitability Analysis

1.1 Basic Checks

  • In the past year KIN was profitable.
  • In the past year KIN had a positive cash flow from operations.
  • KIN had positive earnings in 4 of the past 5 years.
  • Each year in the past 5 years KIN had a positive operating cash flow.
KIN.BR Yearly Net Income VS EBIT VS OCF VS FCFKIN.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M -50M 100M 150M

1.2 Ratios

  • Looking at the Return On Assets, with a value of 3.99%, KIN is in the better half of the industry, outperforming 73.91% of the companies in the same industry.
  • Looking at the Return On Equity, with a value of 19.38%, KIN belongs to the top of the industry, outperforming 82.61% of the companies in the same industry.
  • KIN has a better Return On Invested Capital (9.92%) than 80.43% of its industry peers.
Industry RankSector Rank
ROA 3.99%
ROE 19.38%
ROIC 9.92%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
KIN.BR Yearly ROA, ROE, ROICKIN.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 -40

1.3 Margins

  • The Profit Margin of KIN (5.45%) is better than 69.57% of its industry peers.
  • In the last couple of years the Profit Margin of KIN has grown nicely.
  • KIN has a Operating Margin of 12.02%. This is in the better half of the industry: KIN outperforms 73.91% of its industry peers.
  • In the last couple of years the Operating Margin of KIN has grown nicely.
  • The Gross Margin of KIN (21.80%) is worse than 86.96% of its industry peers.
  • In the last couple of years the Gross Margin of KIN has remained more or less at the same level.
Industry RankSector Rank
OM 12.02%
PM (TTM) 5.45%
GM 21.8%
OM growth 3Y1.62%
OM growth 5YN/A
PM growth 3Y6.79%
PM growth 5YN/A
GM growth 3Y0.47%
GM growth 5YN/A
KIN.BR Yearly Profit, Operating, Gross MarginsKIN.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 -40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. KIN.BR Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so KIN is still creating some value.
  • KIN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
KIN.BR Yearly Shares OutstandingKIN.BR Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
KIN.BR Yearly Total Debt VS Total AssetsKIN.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

  • Based on the Altman-Z score of 1.60, we must say that KIN is in the distress zone and has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of 1.60, KIN is in the better half of the industry, outperforming 63.04% of the companies in the same industry.
  • The Debt to FCF ratio of KIN is 7.85, which is on the high side as it means it would take KIN, 7.85 years of fcf income to pay off all of its debts.
  • KIN's Debt to FCF ratio of 7.85 is in line compared to the rest of the industry. KIN outperforms 50.00% of its industry peers.
  • KIN has a Debt/Equity ratio of 2.10. This is a high value indicating a heavy dependency on external financing.
  • KIN's Debt to Equity ratio of 2.10 is on the low side compared to the rest of the industry. KIN is outperformed by 65.22% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.1
Debt/FCF 7.85
Altman-Z 1.6
ROIC/WACC1.44
WACC6.89%
KIN.BR Yearly LT Debt VS Equity VS FCFKIN.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M 600M 800M

2.3 Liquidity

  • A Current Ratio of 0.55 indicates that KIN may have some problems paying its short term obligations.
  • KIN's Current ratio of 0.55 is on the low side compared to the rest of the industry. KIN is outperformed by 69.57% of its industry peers.
  • KIN has a Quick Ratio of 0.55. This is a bad value and indicates that KIN is not financially healthy enough and could expect problems in meeting its short term obligations.
  • The Quick ratio of KIN (0.53) is worse than 71.74% of its industry peers.
Industry RankSector Rank
Current Ratio 0.55
Quick Ratio 0.53
KIN.BR Yearly Current Assets VS Current LiabilitesKIN.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

7

3. KIN.BR Growth Analysis

3.1 Past

  • KIN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 13.95%, which is quite good.
  • The Earnings Per Share has been growing by 12.02% on average over the past years. This is quite good.
  • KIN shows a strong growth in Revenue. In the last year, the Revenue has grown by 42.30%.
  • The Revenue has been growing by 26.23% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)13.95%
EPS 3Y12.02%
EPS 5YN/A
EPS Q2Q%-2.81%
Revenue 1Y (TTM)42.3%
Revenue growth 3Y4.16%
Revenue growth 5Y26.23%
Sales Q2Q%68.42%

3.2 Future

  • KIN is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 24.40% yearly.
  • KIN is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.29% yearly.
EPS Next Y43.44%
EPS Next 2Y27.47%
EPS Next 3Y24.4%
EPS Next 5YN/A
Revenue Next Year20.41%
Revenue Next 2Y12.88%
Revenue Next 3Y8.17%
Revenue Next 5Y7.29%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
KIN.BR Yearly Revenue VS EstimatesKIN.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 200M 400M 600M 800M
KIN.BR Yearly EPS VS EstimatesKIN.BR Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 1 -1 2 -2 3

More info and screens

Find the best growth stocksShow best growing peers

8

4. KIN.BR Valuation Analysis

4.1 Price/Earnings Ratio

  • KIN is valuated correctly with a Price/Earnings ratio of 15.93.
  • 89.13% of the companies in the same industry are more expensive than KIN, based on the Price/Earnings ratio.
  • Compared to an average S&P500 Price/Earnings ratio of 25.60, KIN is valued a bit cheaper.
  • The Price/Forward Earnings ratio is 10.88, which indicates a very decent valuation of KIN.
  • Based on the Price/Forward Earnings ratio, KIN is valued cheaply inside the industry as 89.13% of the companies are valued more expensively.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 22.84, KIN is valued rather cheaply.
Industry RankSector Rank
PE 15.93
Fwd PE 10.88
KIN.BR Price Earnings VS Forward Price EarningsKIN.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of KIN indicates a somewhat cheap valuation: KIN is cheaper than 67.39% of the companies listed in the same industry.
  • KIN's Price/Free Cash Flow ratio is rather cheap when compared to the industry. KIN is cheaper than 82.61% of the companies in the same industry.
Industry RankSector Rank
P/FCF 7.68
EV/EBITDA 7.36
KIN.BR Per share dataKIN.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

  • KIN's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • KIN has a very decent profitability rating, which may justify a higher PE ratio.
  • KIN's earnings are expected to grow with 24.40% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.37
PEG (5Y)N/A
EPS Next 2Y27.47%
EPS Next 3Y24.4%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

4

5. KIN.BR Dividend Analysis

5.1 Amount

  • KIN has a Yearly Dividend Yield of 1.81%.
  • Compared to an average industry Dividend Yield of 1.07, KIN pays a bit more dividend than its industry peers.
  • KIN's Dividend Yield is comparable with the S&P500 average which is at 1.90.
Industry RankSector Rank
Dividend Yield 1.81%

5.2 History

  • The dividend of KIN decreases each year by -3.24%.
Dividend Growth(5Y)-3.24%
Div Incr Years1
Div Non Decr Years3
KIN.BR Yearly Dividends per shareKIN.BR Yearly Dividends per shareYearly Dividends per share 2019 2020 2023 2024 2025 2026 0.2 0.4 0.6 0.8

5.3 Sustainability

  • KIN pays out 32.78% of its income as dividend. This is a sustainable payout ratio.
DP32.78%
EPS Next 2Y27.47%
EPS Next 3Y24.4%
KIN.BR Yearly Income VS Free CF VS DividendKIN.BR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M -50M 100M
KIN.BR Dividend Payout.KIN.BR Dividend Payout, showing the Payout Ratio.KIN.BR Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

KIN.BR Fundamentals: All Metrics, Ratios and Statistics

KINEPOLIS

EBR:KIN (4/2/2026, 7:00:00 PM)

26.6

+0.1 (+0.38%)

Chartmill FA Rating
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)02-20
Earnings (Next)N/A
Inst Owners16.13%
Inst Owner ChangeN/A
Ins Owners1.8%
Ins Owner ChangeN/A
Market Cap728.04M
Revenue(TTM)822.78M
Net Income(TTM)44.88M
Analysts86
Price Target45.78 (72.11%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.81%
Yearly Dividend0.55
Dividend Growth(5Y)-3.24%
DP32.78%
Div Incr Years1
Div Non Decr Years3
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-7.14%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-8.96%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.57%
Valuation
Industry RankSector Rank
PE 15.93
Fwd PE 10.88
P/S 0.88
P/FCF 7.68
P/OCF 5.25
P/B 3.14
P/tB 13.77
EV/EBITDA 7.36
EPS(TTM)1.67
EY6.28%
EPS(NY)2.45
Fwd EY9.2%
FCF(TTM)3.46
FCFY13.02%
OCF(TTM)5.07
OCFY19.05%
SpS30.06
BVpS8.46
TBVpS1.93
PEG (NY)0.37
PEG (5Y)N/A
Graham Number17.83
Profitability
Industry RankSector Rank
ROA 3.99%
ROE 19.38%
ROCE 13.36%
ROIC 9.92%
ROICexc 12.41%
ROICexgc 17.78%
OM 12.02%
PM (TTM) 5.45%
GM 21.8%
FCFM 11.52%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y1.62%
OM growth 5YN/A
PM growth 3Y6.79%
PM growth 5YN/A
GM growth 3Y0.47%
GM growth 5YN/A
F-Score7
Asset Turnover0.73
Health
Industry RankSector Rank
Debt/Equity 2.1
Debt/FCF 7.85
Debt/EBITDA 2.71
Cap/Depr 54.31%
Cap/Sales 5.34%
Interest Coverage 4.68
Cash Conversion 77.15%
Profit Quality 211.16%
Current Ratio 0.55
Quick Ratio 0.53
Altman-Z 1.6
F-Score7
WACC6.89%
ROIC/WACC1.44
Cap/Depr(3y)49.94%
Cap/Depr(5y)40.94%
Cap/Sales(3y)7.03%
Cap/Sales(5y)6.61%
Profit Quality(3y)253.44%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)13.95%
EPS 3Y12.02%
EPS 5YN/A
EPS Q2Q%-2.81%
EPS Next Y43.44%
EPS Next 2Y27.47%
EPS Next 3Y24.4%
EPS Next 5YN/A
Revenue 1Y (TTM)42.3%
Revenue growth 3Y4.16%
Revenue growth 5Y26.23%
Sales Q2Q%68.42%
Revenue Next Year20.41%
Revenue Next 2Y12.88%
Revenue Next 3Y8.17%
Revenue Next 5Y7.29%
EBIT growth 1Y20.48%
EBIT growth 3Y5.85%
EBIT growth 5YN/A
EBIT Next Year129.3%
EBIT Next 3Y39.36%
EBIT Next 5Y22.96%
FCF growth 1Y-21.7%
FCF growth 3Y-4.34%
FCF growth 5YN/A
OCF growth 1Y-15.27%
OCF growth 3Y0.65%
OCF growth 5YN/A

KINEPOLIS / KIN.BR Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for KINEPOLIS?

ChartMill assigns a fundamental rating of 5 / 10 to KIN.BR.


Can you provide the valuation status for KINEPOLIS?

ChartMill assigns a valuation rating of 8 / 10 to KINEPOLIS (KIN.BR). This can be considered as Undervalued.


How profitable is KINEPOLIS (KIN.BR) stock?

KINEPOLIS (KIN.BR) has a profitability rating of 6 / 10.


What is the financial health of KINEPOLIS (KIN.BR) stock?

The financial health rating of KINEPOLIS (KIN.BR) is 2 / 10.


Is the dividend of KINEPOLIS sustainable?

The dividend rating of KINEPOLIS (KIN.BR) is 4 / 10 and the dividend payout ratio is 32.78%.